Balance Sheet Hygeia Healthcare Holdings Co., Limited

Equities

6078

KYG4712E1035

Healthcare Facilities & Services

Market Closed - Hong Kong S.E. Other stock markets 03:09:08 2025-12-05 am EST			5-day change	1st Jan Change
12.13 ^HKD	-0.49%		-4.03%	-14.94%

Aug. 28	Hygeia Healthcare Holdings Co., Limited Reports Earnings Results for the Half Year Ended June 30, 2025	CI
Aug. 28	Tranche Update on Hygeia Healthcare Holdings Co., Limited's Equity Buyback Plan announced on September 2, 2024.	CI

abfb39ed3ed5759b.74IcXmqcs_50d6tANHF2S4TEdm4rmfibhaDprGVSrsQ.t_JTMCLF8LIyOeYFDEAfBqmRMSdzw4DE4PGDmFcD__fXxGkvC_GGxjc07g

Published financial data: HYGEIA HEALTHCARE HOLDINGS CO., LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	1.4B	2.32B	3.2B	4.08B	4.45B
Total Revenues	1.4B	2.32B	3.2B	4.08B	4.45B
Cost of Goods Sold, Total	922M	1.57B	2.18B	2.81B	3.14B
Gross Profit	480M	745M	1.02B	1.27B	1.31B
Selling General & Admin Expenses, Total	167M	225M	293M	410M	425M
Provision for Bad Debts	-	-	-	-	57.61M
Other Operating Expenses	-4.73M	-6.37M	-11.65M	-13.74M	4.01M
Other Operating Expenses, Total	162M	219M	281M	397M	487M
Operating Income	318M	526M	736M	870M	819M
Interest Expense, Total	-48.17M	-23.08M	-34.88M	-43.17M	-71.84M
Interest And Investment Income	498K	2.16M	17.32M	10.15M	1.51M
Net Interest Expenses	-47.67M	-20.93M	-17.56M	-33.02M	-70.33M
Currency Exchange Gains (Loss)	-1.32M	9.81M	440K	-71K	-
EBT, Excl. Unusual Items	269M	514M	719M	837M	748M
Merger & Related Restructuring Charges	-	-	-	-3.03M	-
Gain (Loss) On Sale Of Investments	43.11M	46.28M	2.39M	15.56M	10.52M
Gain (Loss) On Sale Of Assets	-1.78M	-3.37M	-454K	-4.83M	-6.51M
Asset Writedown	-	-	-	-	-
Other Unusual Items	-57.85M	15.45M	-77.27M	11.17M	-1.4M
EBT, Incl. Unusual Items	253M	573M	643M	856M	751M
Income Tax Expense	75.55M	120M	161M	171M	152M
Earnings From Continuing Operations	177M	453M	482M	685M	598M
Net Income to Company	177M	453M	482M	685M	598M
Minority Interest	-6.98M	-11.75M	-5.09M	-2.02M	-71K
Net Income - (IS)	170M	441M	477M	683M	598M
Net Income to Common Incl Extra Items	170M	441M	477M	683M	598M
Net Income to Common Excl. Extra Items	170M	441M	477M	683M	598M
Per Share Items
Net EPS - Basic	0.38	0.71	0.77	1.08	0.95
Basic EPS - Continuing Operations	0.38	0.71	0.77	1.08	0.95
Basic Weighted Average Shares Outstanding	447M	618M	617M	631M	629M
Net EPS - Diluted	0.38	0.71	0.77	1.08	0.95
Diluted EPS - Continuing Operations	0.38	0.71	0.77	1.08	0.95
Diluted Weighted Average Shares Outstanding	449M	618M	617M	631M	629M
Normalized Basic EPS	0.36	0.5	0.72	0.83	0.74
Normalized Diluted EPS	0.36	0.5	0.72	0.83	0.74
Dividend Per Share	0.12	-	0.15	-	-
Payout Ratio	41.16	16.78	-	13.83	-
Supplemental Items
EBITDA	385M	624M	868M	1.05B	1.08B
EBITA	321M	530M	741M	876M	826M
EBIT	318M	526M	736M	870M	819M
EBITDAR	389M	626M	870M	1.05B	1.08B
Effective Tax Rate - (Ratio)	29.91	20.89	25.09	19.99	20.31
Current Domestic Taxes	58.84M	105M	163M	159M	167M
Current Foreign Taxes	-	-	-	-	-
Total Current Taxes	58.84M	105M	163M	159M	167M
Deferred Foreign Taxes	-	-	-	-	-
Total Deferred Taxes	16.71M	15.05M	-1.65M	12.19M	-15M
Normalized Net Income	161M	310M	444M	521M	468M
Interest Capitalized	-	-	15.39M	31.42M	26.61M
Interest on Long-Term Debt	48.17M	23.08M	158K	238K	653K
Supplemental Operating Expense Items
Marketing Expenses	4.64M	6.29M	6.88M	18.58M	18.35M
Selling and Marketing Expenses	13.74M	20.98M	26.09M	50.57M	53.41M
General and Administrative Expenses	153M	204M	267M	360M	372M
Net Rental Expense, Total	3.35M	2.13M	2M	1.87M	1.83M
Imputed Operating Lease Interest Expense	1.27M	639K	639K	557K	523K
Imputed Operating Lease Depreciation	2.08M	1.5M	1.36M	1.32M	1.31M
Maintenance & Repair Expenses, Total	8.08M	12.84M	11.48M	19.38M	24.37M
Stock-Based Comp., Other (Total)	4.07M	6.76M	38.08M	29.25M	-10.74M
Total Stock-Based Compensation	4.07M	6.76M	38.08M	29.25M	-10.74M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	385M	707M	854M	550M	369M
Trading Asset Securities, Total	2.2B	397M	30.95M	206M	283M
Total Cash And Short Term Investments	2.58B	1.1B	885M	756M	652M
Accounts Receivable, Total	269M	455M	611M	884M	847M
Other Receivables	6.13M	13.36M	18.33M	28.04M	33.24M
Total Receivables	275M	468M	630M	912M	880M
Inventory	59.8M	136M	204M	279M	277M
Prepaid Expenses	-	-	-	-	-
Restricted Cash	-	-	-	12.1M	1.36M
Other Current Assets, Total	5.55M	11.92M	31.02M	15.85M	16.06M
Total Current Assets	2.92B	1.72B	1.75B	1.98B	1.83B
Gross Property Plant And Equipment	1.64B	2.88B	3.49B	5.29B	6B
Accumulated Depreciation	-273M	-365M	-492M	-661M	-917M
Net Property Plant And Equipment	1.37B	2.52B	3B	4.63B	5.08B
Goodwill	300M	2.24B	2.24B	3.72B	3.72B
Other Intangibles, Total	82.6M	146M	149M	221M	219M
Deferred Tax Assets Long-Term	12.29M	17.79M	31.17M	43.89M	48.91M
Other Long-Term Assets, Total	17.88M	50.08M	78.54M	139M	32.13M
Total Assets	4.7B	6.69B	7.24B	10.73B	10.93B
Liabilities
Accounts Payable, Total	118M	308M	396M	687M	549M
Accrued Expenses, Total	70.94M	198M	217M	399M	313M
Short-term Borrowings	-	-	119M	212M	320M
Current Portion of Long-Term Debt	-	34.37M	60.97M	190M	212M
Current Portion of Leases	1.68M	392K	2.73M	793K	3.25M
Current Income Taxes Payable	30.55M	54.85M	72.85M	76.68M	69.38M
Unearned Revenue Current, Total	22.12M	41.53M	37.3M	60.69M	59.44M
Other Current Liabilities	37.21M	217M	119M	318M	269M
Total Current Liabilities	281M	855M	1.03B	1.94B	1.8B
Long-Term Debt	-	1.2B	1.1B	2.32B	2.25B
Long-Term Leases	807K	416K	3.13M	2.44M	8.99M
Unearned Revenue Non Current	26.69M	34.43M	34.57M	36.08M	35.42M
Deferred Tax Liability Non Current	43.6M	115M	127M	168M	158M
Other Non Current Liabilities	7.88M	8.04M	8.31M	9.62M	8.96M
Total Liabilities	360M	2.21B	2.3B	4.48B	4.25B
Common Stock, Total	42K	42K	42K	43K	42K
Additional Paid In Capital	7.12B	7.08B	7.05B	7.63B	7.48B
Retained Earnings	-108M	303M	739M	1.4B	2B
Treasury Stock	-	-	-	-	-18.39M
Comprehensive Income and Other	-2.75B	-2.93B	-2.85B	-2.81B	-2.81B
Total Common Equity	4.27B	4.46B	4.93B	6.23B	6.65B
Minority Interest	73.61M	21.26M	6.31M	21.68M	21.76M
Total Equity	4.34B	4.48B	4.94B	6.25B	6.67B
Total Liabilities And Equity	4.7B	6.69B	7.24B	10.73B	10.93B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	618M	618M	617M	632M	620M
ECS Total Common Shares Outstanding	618M	618M	617M	632M	620M
Book Value / Share	6.91	7.21	8	9.87	10.72
Tangible Book Value	3.88B	2.08B	2.55B	2.29B	2.71B
Tangible Book Value Per Share	6.29	3.36	4.13	3.62	4.37
Total Debt	2.48M	1.23B	1.29B	2.72B	2.79B
Net Debt	-2.58B	127M	404M	1.97B	2.14B
Debt Equivalent Oper. Leases	26.83M	17.07M	16.02M	14.98M	14.65M
Minority Interest, Total (Incl. Fin. Div)	73.61M	21.26M	6.31M	21.68M	21.76M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Finished Goods, Total	47.57M	100M	149M	196M	202M
Inventories - Others	3.38M	6.97M	4.64M	12.25M	13.67M
Buildings, Total	636M	958M	1.36B	2.33B	3B
Machinery, Total	553M	736M	957M	1.35B	1.55B
Full Time Employees	2.99K	5.08K	5.81K	8.24K	8.17K
Part Time Employees	-	-	10	440	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	14.56M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	170M	441M	477M	683M	598M
Depreciation & Amortization - CF	72.12M	106M	142M	194M	275M
Amortization of Goodwill and Intangible Assets - (CF)	2.52M	4.11M	4.95M	5.77M	7.2M
Depreciation & Amortization, Total	74.65M	110M	147M	200M	282M
Amortization of Deferred Charges, Total - (CF)	2.89M	4.37M	6.13M	10.68M	12.74M
(Gain) Loss From Sale Of Asset	1.78M	3.37M	454K	4.83M	6.51M
(Gain) Loss on Sale of Investments - (CF)	-43.11M	-46.28M	-2.39M	-15.56M	-10.52M
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	4.07M	6.76M	38.08M	29.25M	-10.74M
Provision and Write-off of Bad Debts	-	-	-	-	57.61M
Other Operating Activities, Total	135M	58.73M	142M	52.83M	49.61M
Change In Accounts Receivable	-62M	-80.04M	-191M	-30.73M	-2.94M
Change In Inventories	-3.94M	-20.26M	-46.68M	-27.2M	-7.89M
Change In Accounts Payable	16.89M	-51.94M	115M	-124M	-268M
Cash from Operations	296M	426M	685M	783M	707M
Capital Expenditure	-322M	-663M	-593M	-926M	-598M
Sale of Property, Plant, and Equipment	1.35M	20.21M	12.59M	15.23M	9.44M
Cash Acquisitions	-	-2.05B	-147M	-1.77B	-10.31M
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-3.27M	-5.92M	-13.78M	-15.14M	-17.53M
Investment in Marketable and Equity Securities, Total	-2.15B	1.85B	369M	-160M	-65.85M
Other Investing Activities, Total	-	-	-	-12.1M	10.75M
Cash from Investing	-2.48B	-851M	-372M	-2.86B	-671M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	1.2B	394M	2.56B	598M
Total Debt Issued	-	1.2B	394M	2.56B	598M
Short Term Debt Repaid, Total	-11.9M	-	-	-	-
Long-Term Debt Repaid, Total	-1.51M	-90.52M	-424M	-1.29B	-548M
Total Debt Repaid	-13.41M	-90.52M	-424M	-1.29B	-548M
Issuance of Common Stock	2.36B	-	-	682M	-
Repurchase of Common Stock	-	-	-35.83M	-	-168M
Common Dividends Paid	-70M	-74.08M	-	-94.48M	-
Common & Preferred Stock Dividends Paid	-70M	-74.08M	-	-94.48M	-
Other Financing Activities, Total	-98.41M	-277M	-88.07M	-79.85M	-98.3M
Cash from Financing	2.17B	754M	-154M	1.78B	-217M
Foreign Exchange Rate Adjustments	-1.32M	-7.94M	-12.41M	1.35M	-151K
Net Change in Cash	-8.3M	322M	147M	-304M	-181M
Supplemental Items
Cash Interest Paid	-	22.98M	54.46M	79.85M	98.31M
Cash Income Tax Paid (Refund)	53.74M	80.29M	145M	154M	175M
Levered Free Cash Flow	-175M	30.85M	-203M	159M	-98.89M
Unlevered Free Cash Flow	-145M	45.28M	-181M	186M	-53.99M
Change In Net Working Capital	100M	-265M	225M	-343M	235M
Net Debt Issued / Repaid	-13.41M	1.11B	-30.3M	1.27B	49.82M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	5.75	5.77	6.6	6.05	4.72
Return on Total Capital	6.44	6.54	7.7	7.15	5.55
Return On Equity %	8.56	10.28	10.23	12.24	9.26
Return on Common Equity	8.37	10.12	10.15	12.23	9.29
Margin Analysis
Gross Profit Margin %	34.25	32.16	31.83	31.08	29.35
SG&A Margin	11.89	9.74	9.17	10.06	9.56
EBITDA Margin %	27.49	26.94	27.18	25.78	24.27
EBITA Margin %	22.88	22.88	23.18	21.49	18.57
EBIT Margin %	22.7	22.7	23.02	21.35	18.41
Income From Continuing Operations Margin %	12.63	19.57	15.08	16.8	13.46
Net Income Margin %	12.13	19.07	14.92	16.75	13.46
Net Avail. For Common Margin %	12.13	19.07	14.92	16.75	13.46
Normalized Net Income Margin	11.5	13.38	13.9	12.79	10.52
Levered Free Cash Flow Margin	-12.5	1.33	-6.35	3.9	-2.22
Unlevered Free Cash Flow Margin	-10.35	1.96	-5.67	4.56	-1.21
Asset Turnover
Asset Turnover	0.41	0.41	0.46	0.45	0.41
Fixed Assets Turnover	1.13	1.19	1.16	1.07	0.92
Receivables Turnover (Average Receivables)	5.93	6.4	6	5.45	5.14
Inventory Turnover (Average Inventory)	16.25	16.02	12.8	11.62	11.29
Short Term Liquidity
Current Ratio	10.4	2.01	1.71	1.02	1.02
Quick Ratio	10.17	1.84	1.48	0.86	0.85
Operating Cash Flow to Current Liabilities	1.05	0.5	0.67	0.4	0.39
Days Sales Outstanding (Average Receivables)	61.76	57.03	60.87	66.95	71.24
Days Outstanding Inventory (Average Inventory)	22.53	22.79	28.53	31.41	32.42
Average Days Payable Outstanding	47.72	47.29	57.24	68.53	72.07
Cash Conversion Cycle (Average Days)	36.56	32.53	32.16	29.83	31.58
Long Term Solvency
Total Debt/Equity	0.06	27.51	26.1	43.56	41.82
Total Debt / Total Capital	0.06	21.57	20.69	30.34	29.49
LT Debt/Equity	0.02	26.73	22.39	37.11	33.8
Long-Term Debt / Total Capital	0.02	20.96	17.75	25.85	23.84
Total Liabilities / Total Assets	7.66	33.04	31.79	41.73	38.93
EBIT / Interest Expense	6.6	22.77	21.09	20.16	11.39
EBITDA / Interest Expense	8.15	27.54	25.31	24.79	15.32
(EBITDA - Capex) / Interest Expense	1.47	-1.19	8.31	3.35	7.01
Total Debt / EBITDA	0.01	1.94	1.46	2.55	2.54
Net Debt / EBITDA	-6.57	0.2	0.46	1.84	1.94
Total Debt / (EBITDA - Capex)	0.04	-44.93	4.45	18.86	5.55
Net Debt / (EBITDA - Capex)	-36.39	-4.64	1.4	13.63	4.25
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	29.1	65.17	38.02	27.57	9.06
Gross Profit, 1 Yr. Growth %	45.41	57.78	36.58	24.56	3.02
EBITDA, 1 Yr. Growth %	58.89	61.84	39.25	21.01	2.96
EBITA, 1 Yr. Growth %	77.01	65.2	39.83	18.27	-5.42
EBIT, 1 Yr. Growth %	78.1	65.22	39.98	18.29	-5.62
Earnings From Cont. Operations, 1 Yr. Growth %	345.25	155.96	6.33	42.14	-12.65
Net Income, 1 Yr. Growth %	327.7	159.55	8	43.24	-12.4
Normalized Net Income, 1 Yr. Growth %	191.84	92.15	43.33	17.38	-9.97
Diluted EPS Before Extra, 1 Yr. Growth %	175.44	86.84	8.45	40.26	-12.04
Accounts Receivable, 1 Yr. Growth %	31.65	69.13	34.43	44.66	-4.26
Inventory, 1 Yr. Growth %	11.45	128	49.76	36.87	-0.9
Net Property, Plant and Equip., 1 Yr. Growth %	21.68	84.29	19.14	54.41	9.69
Total Assets, 1 Yr. Growth %	112.42	42.24	8.3	48.23	1.81
Tangible Book Value, 1 Yr. Growth %	-760.33	-46.58	22.87	-10.3	18.44
Common Equity, 1 Yr. Growth %	-2.21K	4.42	10.71	26.34	6.73
Cash From Operations, 1 Yr. Growth %	29.53	43.94	60.79	14.22	-9.67
Capital Expenditures, 1 Yr. Growth %	108.69	106	-10.55	56.07	-35.44
Levered Free Cash Flow, 1 Yr. Growth %	157.29	-117.61	-757.97	-178.37	-162.91
Unlevered Free Cash Flow, 1 Yr. Growth %	1.63K	-131.2	-500.15	-202.7	-129.32
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	35.26	46.03	50.99	32.69	17.95
Gross Profit, 2 Yr. CAGR %	42.52	50.19	46.8	30.43	13.28
EBITDA, 2 Yr. CAGR %	65.36	60.36	50.12	29.81	11.46
EBITA, 2 Yr. CAGR %	77.69	71	51.99	28.6	5.58
EBIT, 2 Yr. CAGR %	79.23	71.54	52.08	28.68	5.48
Earnings From Cont. Operations, 2 Yr. CAGR %	755.72	237.59	64.97	22.94	11.43
Net Income, 2 Yr. CAGR %	710.68	233.18	67.43	24.38	12.02
Normalized Net Income, 2 Yr. CAGR %	250.13	136.81	65.96	29.71	2.61
Diluted EPS Before Extra, 2 Yr. CAGR %	645.68	126.86	42.35	23.33	11.08
Accounts Receivable, 2 Yr. CAGR %	30.83	49.22	50.78	39.45	17.69
Inventory, 2 Yr. CAGR %	6.13	59.41	84.78	43.17	16.47
Net Property, Plant and Equip., 2 Yr. CAGR %	13.18	49.75	48.18	35.63	30.14
Total Assets, 2 Yr. CAGR %	53.99	73.82	24.11	26.7	22.85
Tangible Book Value, 2 Yr. CAGR %	159.87	87.82	-18.98	4.98	3.08
Common Equity, 2 Yr. CAGR %	371.63	369	7.52	18.27	16.12
Cash From Operations, 2 Yr. CAGR %	36.07	36.55	52.13	35.52	1.57
Capital Expenditures, 2 Yr. CAGR %	5.79	107.34	35.74	18.15	0.38
Levered Free Cash Flow, 2 Yr. CAGR %	-21.45	-32.7	7.63	127.09	-30.2
Unlevered Free Cash Flow, 2 Yr. CAGR %	-21.41	132.06	11.74	102.72	-45.41
Dividend Per Share, 2 Yr. CAGR %	-	-	11.8	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	32.95	44.58	43.31	42.74	24.3
Gross Profit, 3 Yr. CAGR %	42.81	46.6	45.51	38.98	20.57
EBITDA, 3 Yr. CAGR %	73.51	64.18	52.99	39.71	20.04
EBITA, 3 Yr. CAGR %	98.34	73.42	59.91	39.8	15.95
EBIT, 3 Yr. CAGR %	102.04	74.43	60.3	39.86	15.91
Earnings From Cont. Operations, 3 Yr. CAGR %	56.14	472.28	129.69	56.98	9.7
Net Income, 3 Yr. CAGR %	54.15	454.59	128.88	58.94	10.66
Normalized Net Income, 3 Yr. CAGR %	95.93	186.66	100.31	47.86	14.7
Diluted EPS Before Extra, 3 Yr. CAGR %	31.14	370.1	77.38	41.65	10.19
Accounts Receivable, 3 Yr. CAGR %	31.22	42.52	44.11	48.72	23.02
Inventory, 3 Yr. CAGR %	14.24	36.94	56.12	67.19	26.65
Net Property, Plant and Equip., 3 Yr. CAGR %	19.92	33.15	38.76	50.22	26.36
Total Assets, 3 Yr. CAGR %	38.14	49.97	48.46	31.68	17.79
Tangible Book Value, 3 Yr. CAGR %	77.53	53.37	63.04	-16.19	9.29
Common Equity, 3 Yr. CAGR %	140.54	185.32	189.85	13.46	14.29
Cash From Operations, 3 Yr. CAGR %	64.25	38.64	44.19	38.27	18.38
Capital Expenditures, 3 Yr. CAGR %	11.97	32.1	56.67	42.21	-3.41
Levered Free Cash Flow, 3 Yr. CAGR %	-	-52.29	43.91	-3.17	47.45
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-42.24	178.28	8.64	6.04
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	39.89	39.7	32.57
Gross Profit, 5 Yr. CAGR %	-	-	43.9	39.91	31.64
EBITDA, 5 Yr. CAGR %	-	-	63.75	49.45	34.79
EBITA, 5 Yr. CAGR %	-	-	78.31	53.87	35.44
EBIT, 5 Yr. CAGR %	-	-	80.34	54.45	35.59
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	59.62	209.34	71.98
Net Income, 5 Yr. CAGR %	-	-	59.33	204.99	71.98
Normalized Net Income, 5 Yr. CAGR %	-	-	83.34	108.74	53.29
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	35.51	175.26	47.09
Accounts Receivable, 5 Yr. CAGR %	-	-	38.72	41.29	32.9
Inventory, 5 Yr. CAGR %	-	-	38.47	39.4	38.85
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	30.51	34.14	35.25
Total Assets, 5 Yr. CAGR %	-	-	32.35	40.19	37.63
Tangible Book Value, 5 Yr. CAGR %	-	-	29.71	31.79	35.72
Common Equity, 5 Yr. CAGR %	-	-	74.3	100.61	101.03
Cash From Operations, 5 Yr. CAGR %	-	-	59.29	37.39	25.34
Capital Expenditures, 5 Yr. CAGR %	-	-	20.94	26.33	31.11
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-10.94	7.74
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-4.56	45.05